MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/bs.irn.2026.05.019

Медицинская библиотека · International review of neurobiology · 2026

Metabolic drivers of Alzheimer's disease pathogenesis: Impairments in glucose utilization, lipid homeostasis, and alternative substrate metabolism.

Chaudhary Shiva, Verma Shreya, Kumari Vidisha, Tare Meghana

СтатьяОбзорПеревод в очереди

Аннотация

Alzheimer's disease (AD) is one of the widespread neurodegenerative disorders, marked by the accumulation of amyloid-β plaques, neurofibrillary tangles of hyperphosphorylated Tau protein, and the gradual loss of neurons. While genetic and environmental factors have been associated with its onset, metabolic dysfunction has also been identified as one of the initial and most significant contributors its pathogenesis. The mitochondria are at the centre of this problem; their compromised function affects some crucial aspects of the neuronal health. Neurons have high energy demands so they are quite sensitive to the changes in the supply of the fuel. During AD pathogenesis, the loss of glucose transporters and the downregulation of key glycolytic enzymes deprives neurons of essential energy reserve. This metabolic dysregulation is further exacerbated by dysregulated lipid metabolism, pathological lipid droplet accumulation and ApoE4-driven failures in lipid trafficking which collectively leads to the oxidative stress, neuroinflammation, and Aβ aggregation. This situation is further aggravated by amino acid imbalances specifically within the glutamate-glutamine cycle. To counter this, ketone bodies have emerged as an alternative fuel source, capable of partially bypassing the impaired glucose oxidation while also demonstrating neuroprotective properties. Moreover, systemic metabolic disorders including type 2 diabetes mellitus, insulin resistance, obesity, and metabolic syndrome significantly amplify these deficits, functioning as major risk factors for AD onset and progression. Even the gut-brain axis plays a role in adding to the complexity. Taken together, these metabolic health changes not only reshape our understanding of AD but also open potential prospects for early detection through metabolic biomarkers and for novel therapeutic strategies targeting mitochondrial bioenergetics, glucose restoration, and ketogenic interventions.

Для цитирования: Chaudhary Shiva, Verma Shreya, Kumari Vidisha, Tare Meghana. Metabolic drivers of Alzheimer's disease pathogenesis: Impairments in glucose utilization, lipid homeostasis, and alternative substrate metabolism.. International review of neurobiology. 2026. DOI: 10.1016/bs.irn.2026.05.019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.